Longitudinal Follow‐Up of Adductor Spasmodic Dysphonia Patients After Botulinum Toxin Injection: Quality of Life Results
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Objective: Botulinum toxin injections are used routinely to treat patients with adductor spasmodic dysphonia. After an initial “breathy phase,” most patients experience improvement for a few weeks to months and then a gradual decline until their next injection. In this study, voice‐related quality of life (VRQOL) data were collected at 4 week intervals through one to three injection cycles in an attempt to quantify the proportion of each cycle during which patients experience meaningful benefit. Study Design: Prospective, nonrandomized case series. Methods: Patients receiving stable‐dose botulinum injections for adductor spasmodic dysphonia were invited to participate. Voice recordings and clinical outcomes data were collected by telephone every 4 weeks throughout each injection cycle. Quality of life data were normalized for cycle length and interpolated to generate composite curves. Results: Twenty‐two patients completed data collection for at least one full injection cycle. The average cycle was 25.9 weeks; the mean age was 59.8 years. On a 100‐point scale, the total VRQOL scores peaked at 77.4, at 30% of the cycle, then gradually declined. The social‐emotional (SE) subscale scores were significantly better than the physical subscale scores (P < .05). The total VRQOL score exceeded 75 during only 14% of the cycle (52.6% for SE subscores, 0% for physical subscores). If the threshold is lowered to 70, the total VRQOL exceeded this level during 54.6% of the cycle (69.6% for SE subscores, 44.1% for physical subscores). For the 11 patients completing three full injection cycles, there were no significant differences between the three cycles, and the mean VRQOL scores were similar to the values given above. At the beginning and end of each cycle, the total VRQOL scores averaged 52.8 (56.0 for SE subscale, 50.7 for physical subscale). Conclusion: Although botulinum toxin injections provide significant improvement for these patients, the initial breathy phase and the late declining phase add up to a significant proportion of each cycle spent with a reduced quality of life. At best, the total VRQOL averaged below 80%. This longitudinal study provides a unique look at the effect of this condition and its treatment on these patients' lives. A suitable long‐term treatment for this condition is needed to eliminate the cyclical voice results experienced with the botulinum toxin injection approach.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Validation of an instrument to measure voice-related quality of life (V-RQOL)
Hogikyan, N. D., & Sethuraman, G. (1999) · Journal of Voice · doi:10.1016/s0892-1997(99)80010-1 · Cited by 1,143
Blitzer, A., Brin, M. F., & Stewart, C. F. (1998) · The Laryngoscope · doi:10.1097/00005537-199810000-00003 · Cited by 391
Hogikyan, N. D., Wodchis, W. P., Spak, C., & Kileny, P. R. (2001) · Journal of Voice · doi:10.1016/s0892-1997(01)00060-1 · Cited by 97
Cited by
Botulinum toxin treatment of adductor spasmodic dysphonia: longitudinal functional outcomes
Novakovic, D., Waters, H. H., D'Elia, J. B., & Blitzer, A. (2011) · The Laryngoscope · doi:10.1002/lary.21395 · Cited by 97
Treatment for spasmodic dysphonia: limitations of current approaches
Ludlow, C. L. (2009) · Current Opinion in Otolaryngology & Head and Neck Surgery · doi:10.1097/moo.0b013e32832aef6f · Cited by 84
Quality of life and voice changes after a single injection in patients with ADSD over time
Faham, M., Torabinezhad, F., Murry, T., Dabirmoghaddam, P., Abolghasemi, J., Kamali, M., & Asgari, M. (2019) · Journal of Voice · doi:10.1016/j.jvoice.2018.04.023 · Cited by 10
“Patients have reported that ADSD limits their professional activities, resulting in lower socioeconomic status, and negatively affects self-perception.(26,27) Studies of ADSD using the Voice Handicap Index (VHI-30 or VHI-10) and Voice-Related Quality of Life(7,23,27) to evaluate patients with ADSD after BT injection r…”
BackgroundPatient experience contributing to outcomes of laryngeal botulinum toxin injection
Rutt, A., Kennelly, K. D., & Martinez-Paredes, J. F. (2022) · Journal of Voice · doi:10.1016/j.jvoice.2020.04.037 · Cited by 5
Metadata
- Authors
- Paniello, R. C., Barlow, J., & Serna, J. S.
- Venue
- The Laryngoscope
- Publisher
- Wiley
- Published
- 2008-03
- Volume
- 118
- Issue
- 3
- Pages
- 564-568
- ISSN
- 0023-852X (ISSN-L)
- 1531-4995
- OpenAlex
- W2077130889
- Cited by
- 68
- References
- 3
- FWCI
- 2.81
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Longitudinal Follow‐Up of Adductor Spasmodic Dysphonia Patients After Botulinum Toxin Injection: Quality of Life Results. https://app.cochat.ai/papers/10.1097/mlg.0b013e31815e8be0
- The paper
- Paniello, R. C., Barlow, J., & Serna, J. S. (2008). Longitudinal Follow‐Up of Adductor Spasmodic Dysphonia Patients After Botulinum Toxin Injection: Quality of Life Results. The Laryngoscope. https://doi.org/10.1097/mlg.0b013e31815e8be0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.